Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-07-11FDA Approved: AMLODIPINE BESYLATE — Original Application (POLYGEN PHARMACEUTICALS INC.)
FDA approved the original application for amlodipine besylate by Polygen Pharmaceuticals Inc., broadening access to a generic calcium channe…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Proteus Discover in Subjects With Uncontrolled Hypertension and Type 2 Diabetes [NA]
This update notes the completed status of a clinical trial evaluating Proteus Discover in subjects with uncontrolled hypertension and type 2…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"
Results of Takeda's Blopress drug-use survey in patients with hypertension, including those with metabolic syndrome.
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hypertension Epidemiology Medication Satisfaction Study)
A completed clinical trial evaluating clinical characteristics and medication satisfaction with Kanarb Tablet in Korean hypertensive patient…
-
FDA approval · 2016-07-08FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) filed by Cosette Pharmaceuticals, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-07-08FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for BENICAR (olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2016-07-06Clinical Trial Update: Effect of High-carbohydrate or High-monounsaturated Fat on Blood Pressure: Meta-analysis of Randomized Clinical Trials
This document reports a meta-analysis of randomized trials comparing high-carbohydrate diets with high-monounsaturated fat diets and their e…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Phosphate in Blood Pressure Regulation [NA]
A completed clinical trial update exploring the role of phosphate in regulating blood pressure in the hypertension setting.
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide [Phase 2]
A Phase 2 clinical trial completed evaluating the efficacy, tolerability, and pharmacokinetic-pharmacodynamic relationship of a fixed-dose c…
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension [Phase 3]
A multicenter Phase 3 study evaluated the antihypertensive efficacy and safety of fimasartan 30 mg versus placebo in adults with mild to mod…
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Effect of High- and Low-sodium Intake on the Pharmacokinetics and Pharmacodynamic Effects of Fimasartan [Phase 4]
Phase 4 trial evaluating how high versus low sodium intake affects the pharmacokinetics and pharmacodynamics of fimasartan in hypertension.
-
FDA label_change · 2016-06-29FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
FDA has approved a supplemental application for Cardizem CD (diltiazem hydrochloride) filed by Bausch Health US LLC under NDA 020062.
-
FDA approval · 2016-06-29FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for VALSARTAN AND HYDROCHLOROTHIAZIDE by Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: Renal Sympathetic Denervation for the Management of Chronic Hypertension [NA]
This document reports a completed clinical trial evaluating renal sympathetic denervation for managing hypertension.
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Antihypertensive Efficacy of Fixed Combination Drug [Phase 4]
This Phase 4 clinical trial update assesses the antihypertensive efficacy of a fixed combination drug, but the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: A Single Rising Dose Study of MK-8150 (MK-8150-001) [Phase 1]
Phase 1 single rising dose study of MK-8150 completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Self-Management in Stroke Survivors [Phase 1, Phase 2]
A completed Phase 1/Phase 2 trial from the University of Minnesota evaluating self-management strategies in stroke survivors, including indi…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine [Phase 1]
Phase 1 pharmacokinetic study evaluating potential drug interaction between rosuvastatin and the telmisartan/amlodipine combination.
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Implementation of a Population Health Chronic Disease Management Program
This report notes that the clinical trial examining the implementation of a population health chronic disease management program has complet…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B [Phase 1]
Phase 1 bioequivalence study evaluating a fixed-dose combination of candesartan 16 mg and amlodipine 5 mg for hypertension; status indicates…
-
FDA approval · 2016-06-23FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for a generic fixed-dose combination of candesartan cilexetil and hydrochlorothiazide by Macleods Ph…
-
CLINICAL_TRIALS trial_result · 2016-06-16Clinical Trial Update: Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A [Phase 1]
A Phase 1 bioequivalence study evaluating a fixed-dose combination of candesartan 16 mg and amlodipine 5 mg has completed, in hypertension.
-
CLINICAL_TRIALS trial_result · 2016-06-16Clinical Trial Update: Interactive Multirisk-Factor Intervention for Hypertension (HTN) Blacks [NA]
A completed clinical trial evaluating an interactive multirisk-factor intervention for hypertension in Black participants. The snippet does …
-
FDA approval · 2016-06-14FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic fixed-dose combination of spironolactone and hydrochlorothiazide from Mylan Pharma…
-
FDA approval · 2016-06-14FDA Approved: IRBESARTAN — Original Application (Hisun Pharmaceuticals USA Inc.)
FDA approved the original application for IRBESARTAN (generic irbesartan) by Hisun Pharmaceuticals USA Inc., marking approval of the generic…